A Phase II Trial and Pharmacokinetic Study of Oxaliplatin in Children with Refractory Solid Tumors: A Children's Oncology Group Study

BACKGROUND: Platinating agents are used in the treatment of a spectrum of childhood cancers. Oxaliplatin, a third generation platinum compound, may provide less toxicity and be more effective. A phase 2 study was performed to estimate the response rate to single agent oxaliplatin in patients with re...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Pediatr Blood Cancer
Autori principali: Beaty, Orren, Berg, Stacey, Blaney, Susan, Malogolowkin, Marcio, Krailo, Mark, Knight, Ronald, Schaiquevich, Paula, Stewart, Clinton, Chen, Zhengjia, Nelson, Marvin, Voss, Stephan, Ivy, S. Percy, Adamson, Peter C.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2010
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4665115/
https://ncbi.nlm.nih.gov/pubmed/20658614
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.22544
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi